The Agency for Healthcare Research and Quality (AHRQ) has released a draft paper examining the impact of changes in payment policies on clinical trials. The report discusses the relationship between third-party payments and the recruitment and retention of participants in clinical trials. Among the conclusions of the report: payment policies do affect evidence development in that their impact on clinical trial enrollment results in slower accrual, longer time to complete studies, and the occasional early termination of a study due to a lack of participation. Further, the reports suggest that better coordination among government agencies and between government, third-party payors, sponsors, and trial sites is necessary. Comments on the report are due Jan. 23.
Information: Go to http://www.ahrq.gov/clinic/ta/paypolicy/paypolicy.pdf
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.